Blood tests to detect early stomach changes and cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study looks for a blood “signature” that can spot early, risky stomach changes (before cancer) and stomach cancer. It may help clinicians diagnose earlier and decide who needs closer follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and able to sign consent before any study steps
- You must have social insurance coverage
- If you have stomach pre-cancer changes: you should have untreated glandular atrophy diagnosed (with or without intestinal changes or dysplasia)
- If you have cancer: you should have treatment-naïve stomach adenocarcinoma (upper or lower stomach)
- You generally cannot have conditions or medicines that strongly affect your immune system
- You cannot be pregnant or breastfeeding, and you can’t be in another clinical trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a simple blood test can help find stomach cancer early, before symptoms appear. This could offer a less invasive way to detect the disease compared to a scope procedure.
This study looks for markers in the blood that could show if someone is at risk for stomach cancer or pre-cancerous changes. It aims to help catch problems earlier.
This study looks for marker signals from stomach cancer tissue to improve a detection kit. You may be asked to provide tissue samples, especially if you have a new stomach cancer diagnosis and have not had anti-cancer treatment yet.
This study looks for metabolic markers in your blood and tumor tissue to help find stomach cancer early, predict your prognosis, and watch for recurrence. If you qualify, you would give blood and tumor samples for testing.
This study is looking for people with stomach discomfort who are coming to this hospital for an endoscopy. Researchers will use the test results to help catch stomach cancer early and keep an eye on it after surgery.
This trial looks at tiny pieces of DNA found outside cells in stomach tissue to better understand how gastric (stomach) cancer starts and progresses. It may help future patients by improving how doctors study stomach cancer from biopsy and surgical samples.
Hear when a new Gastric Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.